Vietnam licenses three domestically-produced Covid-19 drugs

The Drug Administration of Vietnam under the Ministry of Health on February 17 issued the list of three COVID-19 treatment drugs containing the active ingredient Molnupiravir, which had been granted certificates of registration for conditional circulation.

The three drugs are Molravir 400 produced by Boston Vietnam Pharma, Movinavir 200 mg manufactured by Mekophar Chemical Pharmaceutical, and Molnupiravir Stella 400 produced by Stellapharm J.V Co., Ltd.

The licensing for these drugs is valid for three years from the date of signing the decision.

During the circulation of the three drugs, based on the monitoring and updating information on their safety and effectiveness, the agency may decide to revoke the granted certificates of registration for circulation./.

VNA